Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Transcription factor TBX4 regulates myofibroblast accumulation and lung fibrosis
Ting Xie, … , Dianhua Jiang, Paul W. Noble
Ting Xie, … , Dianhua Jiang, Paul W. Noble
Published July 11, 2016
Citation Information: J Clin Invest. 2016;126(8):3063-3079. https://doi.org/10.1172/JCI85328.
View: Text | PDF | Corrigendum
Research Article Cell biology Pulmonology

Transcription factor TBX4 regulates myofibroblast accumulation and lung fibrosis

  • Text
  • PDF
Abstract

Progressive tissue fibrosis is a major cause of the morbidity and mortality associated with repeated epithelial injuries and accumulation of myofibroblasts. Successful treatment options are limited by an incomplete understanding of the molecular mechanisms that regulate myofibroblast accumulation. Here, we employed in vivo lineage tracing and real-time gene expression transgenic reporting methods to analyze the early embryonic transcription factor T-box gene 4 (TBX4), and determined that TBX4-lineage mesenchymal progenitors are the predominant source of myofibroblasts in injured adult lung. In a murine model, ablation of TBX4-expressing cells or disruption of TBX4 signaling attenuated lung fibrosis after bleomycin-induced injury. Furthermore, TBX4 regulated hyaluronan synthase 2 production to enable fibroblast invasion of matrix both in murine models and in fibroblasts from patients with severe pulmonary fibrosis. These data identify TBX4 as a mesenchymal transcription factor that drives accumulation of myofibroblasts and the development of lung fibrosis. Targeting TBX4 and downstream factors that regulate fibroblast invasiveness could lead to therapeutic approaches in lung fibrosis.

Authors

Ting Xie, Jiurong Liang, Ningshan Liu, Caijuan Huan, Yanli Zhang, Weijia Liu, Maya Kumar, Rui Xiao, Jeanine D’Armiento, Daniel Metzger, Pierre Chambon, Virginia E. Papaioannou, Barry R. Stripp, Dianhua Jiang, Paul W. Noble

×

Figure 4

Tbx4-lineage cells are highly proliferative upon bleomycin injury in the lung.

Options: View larger image (or click on image) Download as PowerPoint

Tbx4-lineage cells are highly proliferative upon bleomycin injury in th...
(A) Experimental design for inducible TBX4 cell labeling using 1 or 4 doses of tamoxifen 1 week before bleomycin injury for Tbx4LME-CreER Rosa26-tdTomato mice. Lungs were harvested on d21. Tbx4-CreKi Rosa26-tdTomato (Tam, 0.2 mg/g/dose) and Tbx4LME-CreER Confetti (Tam, 0.1 mg/g/dose) were used for all experiments in this figure. (B and D) Representative lung sections from Tbx4LME-CreER Rosa26-tdTomato mice with 1 (B) or 4 (D) doses of tamoxifen injection showing Tbx4-lineage cells in red and nuclei in blue. (C and E) Quantification of Tbx4 cells counted in B and D (from 2 lobes per mouse, n = 9 mice; ****P ≤ 0.0001 by 2-tailed Student’s t test; mean ± SEM). (F) Representative immunofluorescent images of mice from B staining with αSMA, COL1α1, desmin, vimentin, PDGFRβ, and NG2. Arrows show cells with overlap in staining (n = 6 lungs examined). (G) TBX4 cells were marked in Tbx4LME-CreER Confetti mice using 4 doses of tamoxifen. Representative confocal images of a typical colony of TBX4 cells. Cells in clone are enumerated. (H) TBX4 colony size at baseline and d21 after bleomycin injury. n = 9 lungs examined. ****P ≤ 0.0001 by Student’s t test; mean ± SEM. Scale bars: 100 μm (B and D) and 10 μm (F and G). a, alveoli; aw, airway; f, fibrotic foci; m, mesenchyme.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts